National Cooperative Drug Discovery Groups (NCDDGs): A Successful Model for Public Private Partnerships in Cancer Drug Discovery

References

• Adams MW, Kelly RM (1998). Finding and using hyperther-mophilic enzymes. Trends in Biotech 16: 329–332.
   PubMed Web of Science ®Google Scholar
• Anderson HJ, Coleman JE, Andersen RJ, Roberge M (1997): Cytotoxic peptides hemiasterlin, Hemiasterlin A and Hemiasterlin B induce mitotic arrest and abnormal spindle formation. Cancer Chemotherapy and Pharmacology 39: 223–226.
   Google Scholar
• Andersen RJ, Coleman JE, Piers E, Wallace D (1997): Total syn-thesis of (�) Hemiasterlin, a structurally novel tripeptide that exhibits potent cytotoxic activity Tetrahedron Lett 38: 317–320.
   Google Scholar
• Cragg GM, Newman DJ (1999): Discovery and development of antineoplastic agents from natural sources. Cancer Investigation 17: 153–163.
   PubMed Web of Science ®Google Scholar
• Du L, Cheng Y, Ingenhorst G, Tang G, Huang Y, Shen B (2003) Hybrid peptide-polyketide natural products: biosynthesis and prospects towards engineering novel molecules. Genetic Engineering 25: 227–267.
   Google Scholar
• Feling RH, Buchanan GO, Mincer TJ, Kauffman CA, Jensen PR, Fenical W (2003): Salinosporamide A: A highly cytotoxic proteasome inhibitor from a novel microbial source, a marine bacterium of the new genus Salinospora. Angew Chem Int Ed 42: 355–357.
   PubMed Web of Science ®Google Scholar
• Fuino L, Bali P, Wittmann S, Donapaty S, Guo F, Yamaguchi Y, Wang H, Atadja P, Bhalla K (2003): Histone deacetylase inhibitor LAQ824 down-regulates Her-2 and sensitizes human breast cancer cells to trastuzumab, taxotere, gemc-itabine, and epothilone B. Mol Cancer Ther 3: 971–984.
   Google Scholar
• Gollin MA (2002): Linking intellectual property rights with traditional medicine. In: Iwu MiM, Wootton JC, Eds, Ethnomedicine and Drug Discovery. Amsterdam Elsevier, pp. 201-209.
   Google Scholar
• Gollin MA (2002): Elements of commercial biodiversity prospecting agreements. In: Laird SA, Ed. Biodiversity and Traditional Knowledge. Equitable Partnerships in Practice. London Earthscan Publications Ltd. pp. 310–332.
   Google Scholar
• Handelsman J, Rondon MR, Brady SF, Clardy J, Goodman RM (1998): Molecular biological access to the chemistry of unknown soil microbes: a new friontier fir natural products. Chem Biol 5: R245�R249.
   Google Scholar
• Kinder FR Jr, Versace RW, Bair KW, Bontempo JM, Cesarz D, Chen S, Crews P, Czuchta AM, Jagoe CT, Mou Y, Nemzek R, Phillips PE, Tran LD, Wang RM, Weltchek S, Zabludoff S (2001): Synthesis and Antitumor Activity of Ester-Modified Analogues of Bengamide B. J Med Chem 44: 3692–3699.
   PubMed Web of Science ®Google Scholar
• Kinder FR Jr, Wattanasin S, Versace RW, Bair KW, Bontempo J, Green MA, Lu YJ, Marepalli HR, Phillips PE, Roche D, Tran L, Wang RM, Waykole L, Xu DD, Zabludoff 5(2001): Total Syntheses of Bengamides B and E. J Org Chem 66: 2118–2122.
   Google Scholar
• Loganzo, F, Discafani C, Annable T., Beyer C, Musto S, Hardy C, Hernandez R, Baxrer M, Ayral-Kaloustian S, Zask A, Singanallore T, Khafizova G, Asselin A, Poruchynsky M, Fojo T, Nieman J, Andersen R, Greenberg L (2002): HTI286, a synthetic analog of the anti-microtubule tripep-tide hemiasterlin, potently inhibit growth of cultured tumor cells, overcomes resistance to paclitaxel mediated by various mechanism, and demonstrates intravenous and oral in vivo efficacy. Proceedings of the AACR March 2002: 265.
   Google Scholar
• Mincer TJ, Jensen PR, Kauffman CA, Fenical W (2002): Widespread and persistent populations of a major new marine actinomycete taxon in ocean sediments. Appl Envir Microbiol 68: 5005–5011.
   PubMed Web of Science ®Google Scholar
• Nunes M, Kaplan J, Loganzo JF, Zask A, Ayral-Kaloustian S, Greenberg L (2002): Two photoaffinity analogs of HTI-286, a synthetic analog of hemiasterlin, interacts with alpha-tubulin. European J Cancer 38( Suppl.) (7): S119.
   Google Scholar
• Persidis A (1998): Extremophiles. Nature Biotechnology 16: 593–594.
   PubMed Web of Science ®Google Scholar
• Pina IC, Gautschi JT, Wang G-Y-S, Sanders ML, Schmitz FJ, France, D, Cornell-Kennon S, Sambucetti LC, Remiszewski SW, Perez LB, Bair KW, Crews P (2003): Psammaplins from the sponge Pseudoceratina purpurea: Inhibition of both histone deacetylase and DNA methyl-transferase. J Org Chem 68: 3866–3873.
   PubMed Web of Science ®Google Scholar
• Psenner R, Sattler B (1998): Life at the freezing point. Science 280: 2073–2074.
   PubMed Web of Science ®Google Scholar
• Remiszewski S, Bontempo J, Cohen P, Cramer J, Lassota P, Hug M, Perez LB, Thomas H, Versace R, Atadja P (2002): Preclinical efficacy, toxicology and pharmacokinetics of NVP-LAQ824, a novel synthetic histone deacetylase inhibitor. European J Cancer 38(Suppl) (7): S98.
   Google Scholar
• Remiszewski SW, Sambucetti LC, Bair KW, Bontempo J, Cesarz D, Chandramouli N, Chen R, Cheung M, Cornell-Kennon S, Dean K, Diamantidis G, France D, Green MA, Howell KL, Kashi R, Kwon P, Las sota P, Martin, MS, Mou Y, Perez LB, Sharma S, Smith T, Sorensen E, Taplin F, Trogani N, Versace R, Walker H, Weltchek-Engler S, Wood A, Wu A, Atadja P (2003): N-hydroxy-3-phenyl-2-propenamides as novel inhibitors of human histone deacetylase with in vivo antitumor activity: discovery of (2E)-N-hydroxy-344-[[(2-hydroxyethyp[2-(1H-indol-3-ypethyl]amino] methyl] phenyl]-2-propenamide (NVP-LAQ824). J Med Chem 46: 4609-4624.
   PubMed Web of Science ®Google Scholar
• Small EJ, Fratesi P, Reese DM, Strang G, Laus R, Peshwa MV, Valone FH (2000): Immunotherapy of hormone-refractory prostate cancer with antigen-loaded dendritic cells. J Clin Oncol 18: 3894-3903.
   PubMed Web of Science ®Google Scholar
• Strobel G, Daisy B, Castillo U, Harper J (2004): Natural Prod-ucts from Endophytic Microorganisms. J Nat Prod 67: 257-268.
   PubMed Web of Science ®Google Scholar
• Thale Zia, Kinder FR, Bair KW, Bontempo J, Czuchta AM, Versace RW, Phillips PE, Sanders ML, Wattanasin S, Crews P (2001): Bengamides revisited: new structures and antitu-mor studies. J Org Chem 66: 1733-1741.
   PubMed Web of Science ®Google Scholar
• Towbin H, Bair K, DeCaprio J, Eck M, Kim S, Kinder F, Muller D, Schindler P, van Oostrum J, Versace R, Voshol H, Wood J, Zabludoff S, Phillips PE(2003): Proteomics based target identification: Bengamides as a new class of methio-nine aminopeptidase inhibitors. J Biol Chem 278: 52964-52971.
   PubMed Web of Science ®Google Scholar
• Young P (1997): Major microbial diversity initiative recom-mended. ASM News 63: 417-421.
   Google Scholar
• Zengler K, Toledo P, Rappe M, Elkins J, Mathur EJ, Short JM, Keller M (2002): Cultivating the uncultured. Proc NY Acad Sci 99: 15681-15686.
   Google Scholar